Christopher Pazdan - 14 May 2026 Form 4 Insider Report for KORU Medical Systems, Inc. (KRMD)

Reporting relationship: Chief Operating Officer
Issuer ticker: KRMD
Reported as of: 14 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 May 2026, 16:39:51 UTC
Prior SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Thomas Adams - Attorney-in-Fact

Key filing fact

Christopher Pazdan filed Form 4 for KORU Medical Systems, Inc. (KRMD) on 18 May 2026.

Key facts

This page summarizes Christopher Pazdan's Form 4 filing for KORU Medical Systems, Inc. (KRMD).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 18 May 2026, 16:39.

Change

Previous filing in this sequence was filed on 18 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002028813 Primary reporting owner

Pazdan Christopher

Relationship: Chief Operating Officer
Address: C/O KORU MEDICAL SYSTEMS, INC., 100 CORPORATE DRIVE, MAHWAH
Signature: /s/ Thomas Adams - Attorney-in-Fact
Signature date: 18 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KRMD transaction

Common Stock

Options Exercise

Transaction value
Shares: +5,327
Change %: +1.7%
Price: $0.000000^*
Shares after: 310,458
Date: 14 May 2026
Ownership: Direct
Footnotes: F1

KRMD transaction

Common Stock

Tax liability

Transaction value
Shares: -1,470
Change %: -0.47%
Price: $3.94^*
Shares after: 308,988
Date: 14 May 2026
Ownership: Direct
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents common stock issued upon vesting of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock upon vesting.

Footnote F2

Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units.

SEC remarks

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney has been previously filed.